Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligorecurrence

The early results (e.g., patient survival) of RFA for the treatment of patients with NSCLC and pulmonary metastasis from various primary lesions including colorectal cancer, lung cancer, hepatocellular carcinoma, renal cell carcinoma, and sarcoma appear encouraging and suggest the potential to offer...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiraki, Takao, Kanazawa, Susumu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483774/
https://www.ncbi.nlm.nih.gov/pubmed/23125926
http://dx.doi.org/10.1155/2012/196173
_version_ 1782248062539792384
author Hiraki, Takao
Kanazawa, Susumu
author_facet Hiraki, Takao
Kanazawa, Susumu
author_sort Hiraki, Takao
collection PubMed
description The early results (e.g., patient survival) of RFA for the treatment of patients with NSCLC and pulmonary metastasis from various primary lesions including colorectal cancer, lung cancer, hepatocellular carcinoma, renal cell carcinoma, and sarcoma appear encouraging and suggest the potential to offer long-term survival for the patients with oligorecurrence or oligometastasis of lung cancer. The usefulness of RFA for oligorecurrence or oligometastasis of lung cancer should be clarified by prospective studies in the future.
format Online
Article
Text
id pubmed-3483774
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-34837742012-11-02 Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligorecurrence Hiraki, Takao Kanazawa, Susumu Pulm Med Review Article The early results (e.g., patient survival) of RFA for the treatment of patients with NSCLC and pulmonary metastasis from various primary lesions including colorectal cancer, lung cancer, hepatocellular carcinoma, renal cell carcinoma, and sarcoma appear encouraging and suggest the potential to offer long-term survival for the patients with oligorecurrence or oligometastasis of lung cancer. The usefulness of RFA for oligorecurrence or oligometastasis of lung cancer should be clarified by prospective studies in the future. Hindawi Publishing Corporation 2012 2012-10-18 /pmc/articles/PMC3483774/ /pubmed/23125926 http://dx.doi.org/10.1155/2012/196173 Text en Copyright © 2012 T. Hiraki and S. Kanazawa. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Hiraki, Takao
Kanazawa, Susumu
Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligorecurrence
title Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligorecurrence
title_full Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligorecurrence
title_fullStr Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligorecurrence
title_full_unstemmed Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligorecurrence
title_short Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligorecurrence
title_sort lung radiofrequency ablation: potential as a therapy to oligometastasis and oligorecurrence
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483774/
https://www.ncbi.nlm.nih.gov/pubmed/23125926
http://dx.doi.org/10.1155/2012/196173
work_keys_str_mv AT hirakitakao lungradiofrequencyablationpotentialasatherapytooligometastasisandoligorecurrence
AT kanazawasusumu lungradiofrequencyablationpotentialasatherapytooligometastasisandoligorecurrence

Ejemplares similares